Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
European Journal of Pharmacology|March 21, 2006
Pentoxifylline and its major oxidative metabolites exhibit different pharmacological propertiesMarianna Fantin, Luigi Quintieri, Erzsébet Kúsz, et al.
Annals of Surgical Oncology|May 26, 2005
Hyperthermic isolated perfusion with low-dose tumor necrosis factor alpha and doxorubicin for the treatment of limb-threatening soft tissue sarcomasCarlo Riccardo Rossi, Simone Mocellin, Pierluigi Pilati, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2008
A paclitaxel-hyaluronan bioconjugate targeting ovarian cancer affords a potent in vivo therapeutic activityAlessandra Banzato, Sara Bobisse, Maria Rondina, et al.
Biochemical Pharmacology|June 1, 2020
Characterization of water-soluble esters of nitrobenzoxadiazole-based GSTP1-1 inhibitors for cancer treatmentVeronica Di Paolo, Chiara Fulci, Dante Rotili, et al.
European Journal of Medicinal Chemistry|November 9, 2016
Synthesis, structure-activity relationships and biological evaluation of 7-phenyl-pyrroloquinolinone 3-amide derivatives as potent antimitotic agentsDavide Carta, Roberta Bortolozzi, Mattia Sturlese, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|June 7, 2019
Synthesis and characterisation of a new benzamide-containing nitrobenzoxadiazole as a GSTP1-1 inhibitor endowed with high stability to metabolic hydrolysisVeronica Di Paolo, Chiara Fulci, Dante Rotili, et al.
Archives of Biochemistry and Biophysics|July 7, 2026
Protocatechuic acid promotes c-Myc-mediated cell proliferation by directly targeting TRAF2Fiorella Faienza, Daniela Roversi, Federico Carneri, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|January 19, 2017
A new nitrobenzoxadiazole-based GSTP1-1 inhibitor with a previously unheard of mechanism of action and high stabilityChiara Fulci, Dante Rotili, Anastasia De Luca, et al.
Pageof 5